Hosted on MSN
Novo Nordisk Snaps 11-Day Losing Streak After Court Rejects Pfizer’s Challenge To $10B Metsera Deal
Delaware Chancery Judge Morgan Zurn ruled that Pfizer’s objections did not justify delaying Novo’s $10 billion acquisition of obesity-drug startup Metsera. The court decision follows Metsera’s board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results